Sign in to view content

“Real World” U.S. Outcomes of Anti-VEGF Therapy in Neovascular AMD: Risk of Vision Loss is Greatest in Patients with Better Baseline Visual Acuity

Thomas A. Ciulla, MD, MBA, FASRS

Video
Published 2016

Related

ORBIT: A Phase IV Clinical Study - Lessons Learned From Patient Selection Criteria for Ocriplasmin Intravitreal Injection
Mathew W. MacCumber, MD, PhD
Annual Meeting Talks
2016
Bilateral Simultaneous Vitrectomy in Stage 4-5 ROP
Sengul Ozdek, MD, FEBO, FASRS
Annual Meeting Talks
2016
Survey of Patient Utilization of Web-Based Health Data Management Technology in an Outpatient Ophthalmology Practice Setting
Annual Meeting Talks
2016

Category: AMD-Neovascular

See more